Division of Emerging Infectious Disease
Vision
The prevalence of emerging infectious diseases in recent years has resulted in severe impacts on public health, caused economic loss, and resulted in a sense of social uneasiness. Academia Sinica established the Emerging Infectious Disease Division (EIDD) in the National Biotechnology Research Park (NBRP) with the mission of pre-deployment and reservation of R&D capacities to immediately respond to outbreaks of emerging infectious diseases. The EIDD provides BSL-2/ABSL-2 and BSL-3/ABSL-3 core facility services and rapidly develops identification/rapid testing technologies and therapeutic antibodies, drugs, and vaccines, as well as next-generation technologies to fight against severe infectious diseases, such as avian influenza, and COVID-19. The EIDD integrates the resources of the NBRP and collaborates with relevant units in industry, government, academia, and research that help to build up a comprehensive strategy for the prevention and treatment of critical infectious diseases, thereby fulfilling social responsibilities and assisting Taiwan in epidemic prevention.
Mission
.Provide BSL-3/ABSL-3(P3/AP3) facility services on demand
.Rapidly develop identification/testing reagents and tools
.Rapidly develop anti-viral drugs
.Rapidly develop therapeutic antibodies and vaccines
.Establish libraries of infectious biomaterials critical for infectious disease research
.Establish infectious animal models for infectious disease research and drug/vaccine development
.Cultivate talented researchers and specialists for the prevention and control of infectious diseases
